Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | marketing@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street, Wellesley?Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Doxorubicin hydrochloride | C27H29NO11.ClH | 25316-40-9 | Details |
5-Iodo-indirubin-3'-monoxime | C16H10IN3O2 | 331467-03-9 | Details |
A-69412 | C7H10N2O3 | 123606-23-5 | Details |
6-Alpha Naloxol;Alpha-Naloxol | C19H23NO4 | 20410-95-1 | Details |
5-R-Rivaroxaban | C19H18ClN3O5S | 865479-71-6 | Details |
5β-?Dutasteride | C27H30F6N2O2 | 957229-52-6 | Details |
7-Desmethyl-3-hydroxyagomelatine;3-Hydroxy-7-desmethyl agomelatine | C14H15NO3 | 166527-00-0 | Details |
AC710 Mesylate | C32H46N6O7S | 1351522-05-8 | Details |
4-Hydroxynonenal | C9H16O2 | 75899-68-2 | Details |
CCR3 antagonist 1 | C19H21Cl2N3O4S2 | 879399-82-3 | Details |
6-Hydroxybenzbromarone | C17H12Br2O4 | 152831-00-0 | Details |
42-(2-Tetrazolyl)rapamycin | C52H79N5O12 | 221877-56-1 | Details |
A-395 | C26H35FN4O2S | 2089148-72-9 | Details |
Acetylarenobufagin | C26H34O7 | 184673-79-8 | Details |
Abarelix | C72H95ClN14O14 | 183552-38-7 | Details |
7-O-Geranylscopoletin;7-Geranyloxy-6-methoxycoumarin | C20H24O4 | 28587-43-1 | Details |
A 419259;RK-20449 | C29H34N6O | 364042-47-7 | Details |
A 1070722 | C17H13F3N4O2 | 1384424-80-9 | Details |
A2AR-agonist-1 | C20H22N6O4 | 41552-95-8 | Details |
A-437203 | C20H27F3N6OS | 220519-06-2 | Details |
Antiasthmatic Compound 1 | C14H9NO5 | 63768-49-0 | Details |
TRPV antagonist 1 | C26H21F3N2O4S | 1192871-27-4 | Details |
Acetazolamide-d3;Acetazolamide D3 | C4H6N4O3S2 | 1189904-01-5 | Details |
5-HT1A modulator 1 | C21H25N3O2S | 142477-34-7 | Details |
6-Methyl-5-azacytidine | C9H14N4O5 | 105330-94-7 | Details |
5-A-RU hydrochloride | C9H17ClN4O6 | 134452-11-2 | Details |
AAPK-25 | C21H13Cl2N3O2S | 2247919-28-2 | Details |
Abeprazan hydrochloride | C19H18ClF3N2O3S | 1902954-87-3 | Details |
Aclacinomycin A hydrochloride;Aclarubicin hydrochloride | C42H54ClNO15 | 75443-99-1 | Details |
A-887826 | C26H29ClN4O3 | 1266212-81-0 | Details |
Sofiniclin;ABT 894 | C10H11Cl2N3 | 799279-80-4 | Details |
5-HT4 antagonist 1 | C23H36N4O5S | 261766-73-8 | Details |
ABT-418 hydrochloride | C9H14N2O.ClH | 147388-83-8 | Details |
Acetophenazine dimaleate | C53H64N6O11S2 | 5714-00-1 | Details |
A-9758 | C25H23Cl2F3N2O3 | 2055271-22-0 | Details |
7-BIA | C15H18O6 | 1313403-49-4 | Details |
5-HT3 antagonist 3 | C20H21N3O | 120635-47-4 | Details |
5-Dehydroepisterol | C28H44O | 23582-83-4 | Details |
Regorafénib N-oxyde (M2) | C21H15ClF4N4O4 | 835621-11-9 | Details |
PDE IV-IN-1 | C20H23ClN4O2 | 225100-12-9 | Details |
4'-Methylchrysoeriol | C17H14O6 | 4712-12-3 | Details |
5-HT7 agonist 1 | C19H20ClN3 | 334974-31-1 | Details |
Abemaciclib metabolite M2;Abemaciclib Metabolites M2 | C25H28F2N8 | 1231930-57-6 | Details |
6-Raloxifene-β-D-glucopyranoside | C34H37NO9S | 334758-18-8 | Details |
Acetylazide;Acetylkelfizina | C13H14N4O4S | 3590-05-4 | Details |
7α-Hydroxy-4-cholesten-3-one | C27H44O2 | 3862-25-7 | Details |
7-Desmethyl-agomelatine | C14H15NO2 | 152302-45-9 | Details |
7-Chlorokynurenic acid | C10H6ClNO3 | 18000-24-3 | Details |
ABT-100 | C27H19F3N4O3 | 450839-40-4 | Details |
8,?9-?Epoxy-?3-?isobutyryloxy-?10-?(2-?methylbutanoyl)?thymol;8-9-epoxy-3-isobutyryloxy-10-2-methylbutanoyl-thymol | C19H26O5 | 22518-07-6 | Details |
5-Lipoxygenase-In-1 | C23H28N4O2S | 125235-15-6 | Details |
MCHR1 antagonist 1 | C28H33F2N5O5 | 391610-37-0 | Details |
6-Methoxytricin | C18H16O8 | 76015-42-4 | Details |
4-Hydroxypropranolol hydrochloride;(±)-4-hydroxy Propranolol hydrochloride | C16H21NO3.ClH | 14133-90-5 | Details |
ABT-546;A-216546 | C30H48N2O6 | 212481-66-8 | Details |
4-Hydroxyderricin | C21H22O4 | 55912-03-3 | Details |
(5E,9E,13E)-Teprenone;(5E,9E,13E)-Geranylgeranylacetone | C23H38O | 3796-63-2 | Details |
D-α-Tocopherol acetate | C31H52O3 | 58-95-7 | Details |
7-Chlorokynurenic acid sodium salt;7-CKA sodium salt | C10H7ClNNaO3 | 1263094-00-3 | Details |
4-Hydroxymephenytoin | C12H14N2O3 | 61837-65-8 | Details |
11β-HSD1-IN-1 | C18H14ClF4N3O | 1203956-47-1 | Details |
Ac-Gly-BoroPro | C8H15BN2O4 | 886992-99-0 | Details |
(5Z,2E)-CU-3 | C16H12N2O4S3 | 1815598-71-0 | Details |
ABBV-4083 | C53H82FNO17 | 1809266-03-2 | Details |
4-Methylamino antipyrine | C12H15N3O | 519-98-2 | Details |
5-A-RU;5-Amino-6-(D-ribitylamino)uracil | C9H16N4O6 | 17014-74-3 | Details |
A 438079 | C13H9Cl2N5 | 899507-36-9 | Details |
Abatacept;CTLA4lg | 332348-12-6 | Details |
9-Hydroxyellipticine hydrochloride | C17H15ClN2O | 52238-35-4 | Details |
4-Methylamino antipyrine hydrochloride | C12H16ClN3O | 856307-27-2 | Details |
A7132 | C19H16F2N4O3 | 100490-21-9 | Details |
7-Methylguanine | C6H7N5O | 578-76-7 | Details |
Cefoxitin sodium;MK-306;Merxin;Betacef;Cenomycin | C16H18N3NaO7S2 | 33564-30-6 | Details |
5-Hydroxypyrazine-2-Carboxylic Acid | C5H4N2O3 | 34604-60-9 | Details |
(R)-Lansoprazole;R-(+)-Lansoprazole;TAK 390;Dexlansoprazole;T 168390 | C16H14F3N3O2S | 138530-94-6 | Details |
48740 RP | C12H11N3OS | 93363-11-2 | Details |
4-O-Methyl honokiol | C19H20O2 | 68592-15-4 | Details |
7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene | C42H44N2O6S | 1159977-58-8 | Details |
4-Hydroxypropranolol-d7 hydrochloride;4-Hydroxypropranolol D7 hydrochloride;(±)-4-hydroxy Propranolol D7 hydrochloride | C16H15ClD7NO3 | 1219804-03-1 | Details |
ACHN-975 | C20H23N3O4 | 1410809-36-7 | Details |
MAO-B-IN-1 | C16H14F3N3O2S | 1124198-17-9 | Details |
4'-Raloxifene-β-D-glucopyranoside | C34H37NO9S | 334758-19-9 | Details |
Acetyllovastatin | C26H38O6 | 81189-92-6 | Details |
A 1120 | C20H19F3N2O3 | 1152782-19-8 | Details |
ACHP Hydrochloride | C21H25ClN4O2 | 406209-26-5 | Details |
6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)-;6-Quinoxalinecarboxylic acid,2,3-bis(bromomethyl)-;6-Quinoxalinecarboxylic-acid,-2,3-bis_bromomethyl_- | C11H8Br2N2O2 | 32602-11-2 | Details |
GNF-PF-3777 | C15H7N3O4 | 77603-42-0 | Details |
Lipid peroxidation inhibitor 1 | C24H32N2O | 142873-41-4 | Details |
Abeprazan;DWP14012 | C19H17F3N2O3S | 1902954-60-2 | Details |
Fluorothyl | C4H4F6O | 333-36-8 | Details |
6RK73 | C13H17N5O2S | 1895050-66-4 | Details |
5,6-Dihydroxyindole | C8H7NO2 | 3131-52-0 | Details |
Hygromycin B | C20H37N3O13 | 31282-04-9 | Details |
MC-4R Agonist 1 | C30H38ClF2N3O2 | 455957-28-5 | Details |
ABMA | C18H24BrNO | 332108-65-3 | Details |
ACHN-975 TFA | C22H24F3N3O6 | 1410809-37-8 | Details |
Guanosine 5'-triphosphate trisodium salt hydrate;5'-GTP trisodium salt hydrate | C10H19N5NaO15P3 | 207300-85-4 | Details |
AB-680 | C20H24ClFN4O9P2 | 2105904-82-1 | Details |
8-M-PDOT | C14H19NO2 | 134865-70-6 | Details |
6-Phosphogluconic acid | C6H13O10P | 921-62-0 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 |